These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23911182)

  • 1. Noninvasive skin fluorescence spectroscopy for diabetes screening.
    Stirban A
    J Diabetes Sci Technol; 2013 Jul; 7(4):1001-4. PubMed ID: 23911182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive skin fluorescence spectroscopy is comparable to hemoglobin A1c and fasting plasma glucose for detection of abnormal glucose tolerance.
    Olson BP; Matter NI; Ediger MN; Hull EL; Maynard JD
    J Diabetes Sci Technol; 2013 Jul; 7(4):990-1000. PubMed ID: 23911181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined use of fasting plasma glucose and HbA1c (as a screening test)].
    Osawa H; Onuma H; Makino H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():390-3. PubMed ID: 15779410
    [No Abstract]   [Full Text] [Related]  

  • 5. [Screening for type 2 diabetes and impaired glucose tolerance].
    Hirata A; Tominaga M
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():366-71. PubMed ID: 15779405
    [No Abstract]   [Full Text] [Related]  

  • 6. Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C.
    Maynard JD; Rohrscheib M; Way JF; Nguyen CM; Ediger MN
    Diabetes Care; 2007 May; 30(5):1120-4. PubMed ID: 17337498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
    Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM
    Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening of glucose intolerance with fasting blood samples].
    Shiba T
    Nihon Rinsho; 1997 Nov; 55 Suppl():904-9. PubMed ID: 9434585
    [No Abstract]   [Full Text] [Related]  

  • 9. Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China.
    Zhou X; Pang Z; Gao W; Wang S; Zhang L; Ning F; Qiao Q
    Diabetes Care; 2010 Mar; 33(3):545-50. PubMed ID: 20007941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of new WHO diagnostic criteria for diabetes on the prevalence of abnormal glucose tolerance in a heterogeneous Nepali population--the implications of measuring glycated hemoglobin.
    Baral N; Koner BC; Karki P; Ramaprasad C; Lamsal M; Koirala S
    Singapore Med J; 2000 Jun; 41(6):264-7. PubMed ID: 11109341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India.
    Kumpatla S; Aravindalochanan V; Rajan R; Viswanathan V; Kapur A
    Diabetes Res Clin Pract; 2013 Oct; 102(1):60-4. PubMed ID: 24035281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fasting plasma glucose for diagnosis of diabetes mellitus].
    Taminato T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():376-81. PubMed ID: 15779407
    [No Abstract]   [Full Text] [Related]  

  • 13. [Glucose impairment despite normal HbA1c or fasting plasma glucose].
    Gyberg V
    Lakartidningen; 2015 Sep; 112():. PubMed ID: 26418935
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of glycosylated hemoglobin, fasting plasma glucose, and a single post load plasma glucose level in population screening for glucose intolerance.
    Modan M; Halkin H; Karasik A; Lusky A
    Am J Epidemiol; 1984 Mar; 119(3):431-44. PubMed ID: 6702817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An approach to the prevention of type 2 diabetes in industrial healthcare].
    Sumida Y
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():588-96. PubMed ID: 15779445
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glucose intolerance -- diabetes].
    Yamauchi T; Kadowaki T
    Nihon Rinsho; 2008 Sep; 66(9):1753-60. PubMed ID: 18788406
    [No Abstract]   [Full Text] [Related]  

  • 17. Simple and non-invasive screening method for diabetes based on myoinositol levels in urine samples collected at home.
    Takakado M; Takata Y; Yamagata F; Yaguchi M; Hiasa G; Sato S; Funada JI; Kawazu S; Osawa H
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities].
    GoĊ‚embiewska E
    Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
    Mainguy C; Bellon G; Delaup V; Ginoux T; Kassai-Koupai B; Mazur S; Rabilloud M; Remontet L; Reix P
    J Pediatr Endocrinol Metab; 2017 Jan; 30(1):27-35. PubMed ID: 27977404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore.
    Lim WY; Ma S; Heng D; Tai ES; Khoo CM; Loh TP
    Sci Rep; 2018 Aug; 8(1):12419. PubMed ID: 30127499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.